Imaging data from the CONTENTed study suggest the type 2 inflammation that drives severe asthma may affect more than the airways.
|Articles|August 12, 2021
Pharmacy Clinical Pearl of the Day: COPD vs Asthma
Author(s)Saro Arakelians, PharmD
Both asthma and chronic obstructive pulmonary disease cause swelling in the airways that makes it difficult to breathe.
Advertisement
Clinical Pearl of the Day: Chronic Obstructive Pulmonary Disease (COPD) vs Asthma
Explanation:
- Asthma and COPD are lung diseases.
- Both cause swelling in the airways that makes it difficult for patients to breathe.
- With asthma, the swelling is often triggered by something the patient is allergic to, such as pollen or mold, or by physical activity.
COPD is the name given to a group of lung diseases that include emphysema and chronic bronchitis.
Reference:
Advertisement
Related to this article
A pharmacist-led collaborative drug therapy management program at NYC Health + Hospitals/Bellevue reported high patient satisfaction, and every surveyed patient said they felt respected and supported by their pharmacist.
A Novo Nordisk-funded claims analysis of adults with type 2 diabetes found an adjusted HR of 1.06 for MACE with switching, though the findings cannot show causation.
Invasive pneumococcal disease may be the first sign of undiagnosed blood cancers and antibody deficiencies in adults, a new study finds.
A new analysis finds a significant weight loss edge for tirzepatide under one estimand but not another; no head-to-head trial exists at these doses.
In SCOUT-HCM, mavacamten reduced the Valsalva LVOT gradient by 48 mm Hg versus placebo in adolescents. REMS, echo monitoring, and CYP interactions still apply in the new population.
Indirect comparison links orforglipron 17.2 mg to 1.5% more weight loss and 0.3% more A1C lowering than oral semaglutide 25 mg in adults with type 2 diabetes.
Pharmacists can help overcome influenza vaccine hesitancy by correcting common misconceptions, routinely asking every patient about vaccination, and leveraging their standing as trusted health care professionals.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Tirzepatide Linked to More Weight Loss Than Semaglutide 7.2 mg
2
Pharmacist, Advocate, Ally: Delivering Comprehensive Gender-Affirming Care
3
Semaglutide 2 mg Tied to Lower MACE Risk Than Tirzepatide Switch
4
Statin Myths: Why Patients Avoid Cholesterol-Lowering Therapy
5